Related Experiment Video
Updated: Mar 9, 2026
07:52
Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma
Published on: January 9, 2019
20.6K
Multimodality Technologies in the Assessment of Hematolymphoid Neoplasms
Shiyong Li, David L Jaye, Kyle T Bradley
1From the Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia.
Archives of Pathology & Laboratory Medicine
|January 6, 2017
Summary
Accurate diagnosis of hematolymphoid neoplasms requires integrating morphology, immunophenotyping, and genotypic studies. This multiparameter approach aids in classification, treatment stratification, and monitoring disease response.
Area of Science:
- Hematology
- Oncology
- Pathology
Background:
- Morphologic examination by light microscopy is the primary method for assessing hematolymphoid neoplasms.
- Immunophenotypic analysis (immunohistochemistry, flow cytometry) is crucial for differentiation and detecting minimal residual disease.
- Genotypic studies are essential for precise subclassification according to the World Health Organization classification.
Purpose of the Study:
- To highlight the necessity of an integrated multiparameter approach for accurate hematolymphoid neoplasm assessment.
- To emphasize the complementary roles of morphology, immunophenotyping, and genotypic studies.
- To underscore the impact of these methods on targeted immunotherapy, prognostication, and treatment monitoring.
Main Methods:
- Light microscopy for initial morphologic assessment.
- Immunophenotypic analysis including immunohistochemistry and flow cytometry.
- Genotypic studies such as cytogenetics, FISH, DNA microarray, PCR, and next-generation sequencing.
Main Results:
- Morphology provides initial assessment, while immunophenotyping clarifies differentiation and detects minimal disease.
- Genotypic studies enable precise subclassification, clonality assessment, and treatment stratification.
- Integrated approaches enhance diagnostic accuracy and guide therapeutic decisions.
Conclusions:
- An integrated multiparameter approach combining morphology, immunophenotyping, and genotypic studies is indispensable for accurate hematolymphoid neoplasm diagnosis.
- This comprehensive strategy is vital for subclassification, determining appropriate treatments, and monitoring patient response.
- Utilizing these advanced techniques improves patient outcomes through personalized medicine and precise disease management.
